Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$9.81 USD
0.00 (0.00%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $9.82 +0.01 (0.10%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AMRX 9.81 0.00(0.00%)
Will AMRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AMRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMRX
Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet
Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out?
AMRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts See a 27.66% Upside in Amneal (AMRX): Can the Stock Really Move This High?
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Here's Why Momentum in Amneal (AMRX) Should Keep going
Other News for AMRX
Is AMRX primed for upward momentum? Crossed Above 20 Day Moving Average shows up after climbing 2.08%
AMRX Fell Below 20 Day Moving Average on September 18
TPG GP A, LLC Reduces Stake in Life Time Group Holdings Inc
AMRX forms 1,2,3 Pullback Bullish on September 16
Is AMRX gaining bearish strength? MACD Bearish Signal Line Cross shows up after sliding 2.1%